Omnicare (NYSE: OCR ) reported earnings on Feb. 19. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Omnicare beat slightly on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted slightly. Non-GAAP earnings per share grew significantly. GAAP earnings per share grew significantly.
Gross margins increased, operating margins contracted, net margins grew.
Omnicare tallied revenue of $1.53 billion. The eight analysts polled by S&P Capital IQ wanted to see a top line of $1.51 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.86. The eight earnings estimates compiled by S&P Capital IQ predicted $0.85 per share. Non-GAAP EPS of $0.86 for Q4 were 48% higher than the prior-year quarter's $0.58 per share. (The prior-year quarter included -$0.06 per share in earnings from discontinued operations.) GAAP EPS of $0.54 for Q4 were 100% higher than the prior-year quarter's $0.27 per share. (The prior-year quarter included -$0.06 per share in earnings from discontinued operations.)
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 24.6%, 150 basis points better than the prior-year quarter. Operating margin was 8.0%, 60 basis points worse than the prior-year quarter. Net margin was 3.9%, 190 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.55 billion. On the bottom line, the average EPS estimate is $0.86.
Next year's average estimate for revenue is $6.22 billion. The average EPS estimate is $3.53.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 224 members out of 245 rating the stock outperform, and 21 members rating it underperform. Among 89 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 86 give Omnicare a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Omnicare is outperform, with an average price target of $40.00.
Is Omnicare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.